Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries

Infection, Genetics and Evolution

Volumn 26, Issue , 2014, Pages 172-179

  Cui, Yujun ^a   Yang, Xianwei ^a   Xiao, Xiao ^a   Anisimov, Andrey P ^b   Li, Dongfang ^c   Yan, Yanfeng ^a   Zhou, Dongsheng ^a   Rajerison, Minoarisoa ^d   Carniel, Elisabeth ^e   Achtman, Mark ^f,g   Yang, Ruifu ^a   Song, Yajun ^a,f  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY   (Russian Federation)

^c BGI SHENZHEN   (China)

^d INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^e INSTITUT PASTEUR   (France)

^f UNIVERSITY COLLEGE CORK   (Ireland)

^g UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

EV76; Genetic variation; Live vaccine; Yersinia pestis

Indexed keywords

PLAGUE VACCINE; LIVE VACCINE;

ARTICLE; BACTERIAL STRAIN; CHINA; GENE; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLAGUE; PRIORITY JOURNAL; PYRE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; YERSINIA PESTIS; CLASSIFICATION; GENETICS; GENOTYPE; GEOGRAPHY; HUMAN; IMMUNOLOGY; INDEL MUTATION; ISOLATION AND PURIFICATION; MOLECULAR EVOLUTION; MUTATION; PHYLOGENY; PHYLOGEOGRAPHY;

DNA MUTATIONAL ANALYSIS; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; GEOGRAPHY; HUMANS; INDEL MUTATION; MUTATION; PHYLOGENY; PHYLOGEOGRAPHY; PLAGUE; PLAGUE VACCINE; POLYMORPHISM, SINGLE NUCLEOTIDE; VACCINES, ATTENUATED; YERSINIA PESTIS;

EID: 84902472387     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.05.023     Document Type: Article

References (38)

1. Achtman M. Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu. Rev. Microbiol. 2008, 62:53-70.
2. Alvarez M.L., Cardineau G.A. Prevention of bubonic and pneumonic plague using plant-derived vaccines. Biotechnol. Adv. 2010, 28:184-196.
3. Anisimov A.P., Lindler L.E., Pier G.B. Intraspecific diversity of Yersinia pestis. Clin. Microbiol. Rev. 2004, 17:434-464.
4. Conrad T.M., Joyce A.R., Applebee M.K., Barrett C.L., Xie B., Gao Y., Palsson B.O. Whole-genome resequencing of Escherichia coli K-12 MG1655 undergoing short-term laboratory evolution in lactate minimal media reveals flexible selection of adaptive mutations. Genome Biol. 2009, 10:R118.
5. Cui Y., Yu C., Yan Y., Li D., Li Y., Jombart T., Weinert L.A., Wang Z., Guo Z., Xu L., Zhang Y., Zheng H., Qin N., Xiao X., Wu M., Wang X., Zhou D., Qi Z., Du Z., Wu H., Yang X., Cao H., Wang H., Wang J., Yao S., Rakin A., Falush D., Balloux F., Achtman M., Song Y., Wang J., Yang R. Historical variations in mutation rate in an epidemic pathogen, Yersinia pestis. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:577-582.
6. Derbise A., Cerda Marin A., Ave P., Blisnick T., Huerre M., Carniel E., Demeure C.E. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague. PLoS Negl. Trop. Dis. 2012, 6:e1528.
7. Feodorova V.A., Corbel M.J. Prospects for new plague vaccines. Expert Rev. Vaccines 2009, 8:1721-1738.
8. Gallut J., Girard G. Action of chlorpromazine on experimental poisoning and infection of the mouse by Pasteurella pestis (EV vaccinal strain). Ann. Inst. Pasteur. (Paris) 1961, 100:672-676.
9. Girard G. Immunity in plague. Acquisitions supplied by 30 years of work on the "Pasteurella pestis EV" (Girard and Robic) strain. Biol. Med. (Paris) 1963, 52:631-731.
10. Girard G., Robic J. Current status of the plague in Madagascar and vaccinal prophylaxis with the aid of the EV virus-vaccine. Bull. Soc. Path. Exot. 1942, 35:43-49.
11. Greenfield R.A., Drevets D.A., Machado L.J., Voskuhl G.W., Cornea P., Bronze M.S. Bacterial pathogens as biological weapons and agents of bioterrorism. Am. J. Med. Sci. 2002, 323:299-315.
12. Guiyoule A., Grimont F., Iteman I., Grimont P.A., Lefevre M., Carniel E. Plague pandemics investigated by ribotyping of Yersinia pestis strains. J. Clin. Microbiol. 1994, 32:634-641.
13. Hawgood B.J. Alexandre Yersin (1863-1943): discoverer of the plague bacillus, explorer and agronomist. J. Med. Biogr. 2008, 16:167-172.
14. Kurtz S., Phillippy A., Delcher A.L., Smoot M., Shumway M., Antonescu C., Salzberg S.L. Versatile and open software for comparing large genomes. Genome Biol. 2004, 5:R12.
15. Kutyrev V.V., Filippov A.A., Shavina N., Protsenko O.A. Genetic analysis and simulation of the virulence of Yersinia pestis. Mol. Gen. Mikrobiol. Virusol. 1989, 42-47.
16. Levinson G., Gutman G.A. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol. Biol. Evol. 1987, 4:203-221.
17. Li H., Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010, 26:589-595.
18. Li Y., Cui Y., Cui B., Yan Y., Yang X., Wang H., Qi Z., Zhang Q., Xiao X., Guo Z., Ma C., Wang J., Song Y., Yang R. Features of variable number of tandem repeats in Yersinia pestis and the development of a hierarchical genotyping scheme. PLoS One 2013, 8:e66567.
19. Li Y., Dai E., Cui Y., Li M., Zhang Y., Wu M., Zhou D., Guo Z., Dai X., Cui B., Qi Z., Wang Z., Wang H., Dong X., Song Z., Zhai J., Song Y., Yang R. Different region analysis for genotyping Yersinia pestis isolates from China. PLoS One 2008, 3:e2166.
20. Meyer K.F. Effectiveness of live or killed plague vaccines in man. Bull. World Health Organ. 1970, 42:653-666.
21. Meyer K.F., Cavanaugh D.C., Bartelloni P.J., Marshall J.D. Plague immunization. I. Past and present trends. J. Infect. Dis. 1974, 129(Suppl.):S13-18.
22. Morelli G., Song Y., Mazzoni C.J., Eppinger M., Roumagnac P., Wagner D.M., Feldkamp M., Kusecek B., Vogler A.J., Li Y., Cui Y., Thomson N.R., Jombart T., Leblois R., Lichtner P., Rahalison L., Petersen J.M., Balloux F., Keim P., Wirth T., Ravel J., Yang R., Carniel E., Achtman M. Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat. Genet. 2010, 42:1140-1143.
23. Parkhill J., Wren B.W., Thomson N.R., Titball R.W., Holden M.T., Prentice M.B., Sebaihia M., James K.D., Churcher C., Mungall K.L., Baker S., Basham D., Bentley S.D., Brooks K., Cerdeno-Tarraga A.M., Chillingworth T., Cronin A., Davies R.M., Davis P., Dougan G., Feltwell T., Hamlin N., Holroyd S., Jagels K., Karlyshev A.V., Leather S., Moule S., Oyston P.C., Quail M., Rutherford K., Simmonds M., Skelton J., Stevens K., Whitehead S., Barrell B.G. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413:523-527.
24. Pearson T., Okinaka R.T., Foster J.T., Keim P. Phylogenetic understanding of clonal populations in an era of whole genome sequencing. Infect. Genet. Evol. 2009, 9:1010-1019.
25. Podladchikova O.N., Rykova V.A., Ivanova V.S., Eremenko N.S., Lebedeva S.A. Study of pgm mutation mechanism in Yersinia pestis (plague pathogen) vaccine strain EV76. Mol. Gen. Mikrobiol. Virusol. 2002, 14-19.
26. Quenee L.E., Hermanas T.M., Ciletti N., Louvel H., Miller N.C., Elli D., Blaylock B., Mitchell A., Schroeder J., Krausz T., Kanabrocki J., Schneewind O. Hereditary hemochromatosis restores the virulence of plague vaccine strains. J. Infect. Dis. 2012, 206:1050-1058.
27. Saltykova R.A., Faibich M.M. Experience from a 30-year study of the stability of the properties of the plague vaccine strain EV in the USSR. Zh. Mikrobiol. Epidemiol. Immunobiol. 1975, 3-8.
28. Smiley S.T. Current challenges in the development of vaccines for pneumonic plague. Expert Rev. Vaccines 2008, 7:209-221.
29. Song Y., Roumagnac P., Weill F.X., Wain J., Dolecek C., Mazzoni C.J., Holt K.E., Achtman M. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A. J. Antimicrob. Chemother. 2010, 65:1631-1641.
30. Stenseth N.C., Atshabar B.B., Begon M., Belmain S.R., Bertherat E., Carniel E., Gage K.L., Leirs H., Rahalison L. Plague: past, present, and future. PLoS Med. 2008, 5:e3.
31. Sun W., Curtiss R. Rational considerations about development of live attenuated Yersinia pestis vaccines. Curr. Pharm. Biotechnol. 2014, 14:878-886.
32. Sun W., Roland K.L., Curtiss R.I. Developing live vaccines against Yersinia pestis. J. Infect. Dev. Ctries. 2011, 5:614-627.
33. Titball R.W., Williamson E.D. Yersinia pestis (plague) vaccines. Expert. Opin. Biol. Ther. 2004, 4:965-973.
34. Vogler A.J., Keys C.E., Allender C., Bailey I., Girard J., Pearson T., Smith K.L., Wagner D.M., Keim P. Mutations, mutation rates, and evolution at the hypervariable VNTR loci of Yersinia pestis. Mutat Res. 2007, 616:145-158.
35. Wang X., Zhang X., Zhou D., Yang R. Live-attenuated Yersinia pestis vaccines. Expert Rev. Vaccines 2013, 12:677-686.
36. Welkos S., Pitt M.L., Martinez M., Friedlander A., Vogel P., Tammariello R. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 2002, 20:2206-2214.
37. WHO Human plague: review of regional morbidity and mortality, 2004-2009. Wkly. Epidemiol. Rec. 2009, 85:40-45.
38. Zhou D., Han Y., Dai E., Song Y., Pei D., Zhai J., Du Z., Wang J., Guo Z., Yang R. Defining the genome content of live plague vaccines by use of whole-genome DNA microarray. Vaccine 2004, 22:3367-3374.